Skip to main content
SpringerLink
Log in

Current and future treatments in multiple system atrophy

  • Movement Disorders
  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References and Recommended Reading

  1. Graham JG, Oppenheimer DR:Orthostatic hypotension and nicotinic sensitivity in a case of multiple systems atrophy.J Neurol Neurosurg Psychiatry 1969, 32:28–34.

    Article  PubMed  CAS  Google Scholar 

  2. Gilman S, Low PA, Quinn N, et al.:Consensus statement on the diagnosis of multiple system atrophy.J Neurol Sci 1999, 163:94–98.

    Article  PubMed  CAS  Google Scholar 

  3. Schrag A, Ben-Shlomo Y, Quinn NP:Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study.Lancet 1999, 354:1771–1775.

    Article  PubMed  CAS  Google Scholar 

  4. Tison F, Yekhlef F, Chrysostome V, Sourgen C:Prevalence of multiple system atrophy.Lancet 2000, 355:495–496.

    Article  PubMed  CAS  Google Scholar 

  5. Ben-Shlomo Y, Wenning GK, Tison F, Quinn NP:Survival of patients with pathologically proven multiple system atrophy: a meta-analysis.Neurology 1997, 48:384–393.

    PubMed  CAS  Google Scholar 

  6. Wenning GK, Ben Shlomo Y, Magalhaes M, et al.:Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.Brain 1994, 117:835–845.

    Article  PubMed  Google Scholar 

  7. Of major importance Quinn, NP:How to diagnose multiple system atrophy.Mov Disord 2005, 20(Suppl 12):S5. A succinct guideline to establishing a diagnosis of MSA, including diagnostic criteria, differential diagnosis, exclusion criteria, and anciallary test.

  8. Chen R, Ashby P, Lang AE:Stimulus-sensitive myoclonus in akinetic-rigid syndromes.Brain 1992, 115:1875–1888.

    Article  PubMed  Google Scholar 

  9. Salazar G, Valls-Sole J, Marti MJ, et al.:Postural and action myoclonus in patients with parkinsonian type multiple system atrophy.Dov Disord 2000, 15:77–83.

    Article  CAS  Google Scholar 

  10. Steiger MJ, Pires M, Scaravilli F, et al.:Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration.Mov Disord 1992, 7:71–77.

    Article  PubMed  CAS  Google Scholar 

  11. Of major importance Wenning GK, Colosimo C, Geser C, Poewe W:Multiple system atrophy.Lancet Neurol 2004, 3:93–103. An excellent review of MSA, including epidemiology, diagnosis, and therapeutic management.

    Article  PubMed  Google Scholar 

  12. Wenning GK, Geser F, Stampfer-Kountchev M, Tison F:Multiple system atrophy: an update.Mov Disord 2003, 18(Suppl 6):S34-S42.

    Article  PubMed  Google Scholar 

  13. Plazzi G, Corsini R, Provini F, et al.:REM sleep behavior disorders in multiple system atrophy.Neurology 1997, 48:1094–1097.

    PubMed  CAS  Google Scholar 

  14. Fearnley JM, Lees AJ:Striatonigral degeneration. A clinicopathological study.Brain 1990, 113:1823–1842.

    Article  PubMed  Google Scholar 

  15. Testa D, Savoiardo M, Fetoni V, et al.:Multiple system atrophy. Clinical and MR observations on 42 cases.Ital J Neurol Sci 1993, 14:211–216.

    Article  PubMed  CAS  Google Scholar 

  16. Geser F, Seppi K, Stampfer-Kountchev M, et al.:The European Multiple System Atrophy-Study Group (EMSA-SG).J Neural Transm 2005, 112:1677–1686.

    Article  PubMed  CAS  Google Scholar 

  17. Hughes AJ, Colosimo C, Kleedorfer B, et al.:The dopaminergic response in multiple system atrophy J Neurol Neurosurg Psychiatry 1992, 55:1009–1013.

    Article  PubMed  CAS  Google Scholar 

  18. Parati EA, Fetoni V, Geminiani GC, et al.:Response to L-DOPA in multiple system atrophy.Clin Neuropharmacol 1993, 16:139–144.

    Article  PubMed  CAS  Google Scholar 

  19. Rajput AH, Kazi KH, Rozdilsky B:Striatonigral degeneration response to levodopa therapy.J Neurol Sci 1972, 16:331–341.

    Article  PubMed  CAS  Google Scholar 

  20. Colosimo C, Abanese A, Hughes AJ, et al.:Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson’s disease.Arch Neurol 1995, 52:294–298.

    PubMed  CAS  Google Scholar 

  21. Wenning GK, Ben-Shlomo Y, Magalhaes M, et al.:Clinicopathological study of 35 cases of multiple system atrophy.J Neurol Neurosurg Psychiatry 1995, 58:160–166.

    Article  PubMed  CAS  Google Scholar 

  22. Tarsy D:Initial treatment of Parkinson’s disease.Curr Treat Options Neurol 2006, 8:224–235.

    Article  PubMed  Google Scholar 

  23. Quinn N:Unilateral facial dystonia in multiple system atrophy.Mov Disord 1992, 7(Suppl 1):79.

    Google Scholar 

  24. van Leeuwen RB, Perquin WV:Bromocriptine therapy in striatonigral degeneration.J Neurol Neurosurg Psychiatry 1988, 51:592.

    Article  PubMed  Google Scholar 

  25. Rossi P, Colosimo C, Moro E, et al.:Acute challenge with apomorphine and levodopa in Parkinsonism.Eur Neurol 2000, 43:95–101.

    Article  PubMed  CAS  Google Scholar 

  26. Wenning GK:Placebo-controlled trial of amantadine in multiple-system atrophy.Clin Neuropharmacol 2005, 28:225–227.

    Article  PubMed  CAS  Google Scholar 

  27. Lava NS, Factor SA:Focal myopathy as a cause of anterocollis in Parkinsonism.Mov Disord 2001, 16:754–756.

    Article  PubMed  CAS  Google Scholar 

  28. Mancini F, Zangaglia R, Cristina S, et al.:Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.Mov Disord 2003, 18:685–688.

    Article  PubMed  Google Scholar 

  29. Ondo WG, Hunter C, Moore W:A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease.Neurology 2004, 62:37–40.

    PubMed  CAS  Google Scholar 

  30. Wenning GK, Geser F, Poewe W:Therapeutic strategies in multiple system atrophy.Mov Disord 2005, 20(Suppl 12): S67-S76.

    Article  PubMed  Google Scholar 

  31. Zesiewicz TA, Helal M, Hauser RA:Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson’s disease.Mov Disord 2000, 15:305–308.

    Article  PubMed  CAS  Google Scholar 

  32. Liu Z, Sakakibara R, Odaka T, et al.:Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients.Mov Disord 2005, 20:680–686.

    Article  PubMed  Google Scholar 

  33. Sakakibara R, Matsuda S, Uchiyama T, et al.:The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria.Clin Auton Res 2003, 13:106–108.

    Article  PubMed  Google Scholar 

  34. Ito T, Sakakibara R, Yasuda K, et al.:Incomplete emptying and urinary retention in multiple-system atrophy: when does it occur and how do we manage it?.Mov Disord 2006, 21:816–823.

    Article  PubMed  Google Scholar 

  35. Iranzo A, Santamaria J, Rye DB, et al.:Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD.Neurology 2005, 65:247–252.

    Article  PubMed  CAS  Google Scholar 

  36. Ghorayeb I, Yekhlef F, Bioulac B, Tison F:Continuous positive airway pressure for sleep-related breathing disorders in multiple system atrophy: long-term acceptance.Sleep Med 2005, 6:359–362.

    Article  PubMed  Google Scholar 

  37. Schenck CH, Mahowald MW:Rapid eye movement sleep parasomnias.Neurol Clin 2005, 23:1107–1126.

    Article  PubMed  Google Scholar 

  38. Boeve BF, Silber MH, Ferman TJ:Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients.Sleep Med 2003, 4:281–284.

    Article  PubMed  Google Scholar 

  39. Hooten WM, Melin G, Richardson JW:Response of the Parkinsonian symptoms of multiple system atrophy to ECT.Am J Psychiatry 1998, 155:1628.

    PubMed  CAS  Google Scholar 

  40. Roane DM, Rogers JD, Helew L, Zarate J:Electroconvulsive therapy for elderly patients with multiple system atrophy: a case series.Am J Geriatr Psychiatry 2000, 8:171–174.

    PubMed  CAS  Google Scholar 

  41. Ruxin RJ, Ruedrich S:ECT in combined multiple system atrophy and major depression.Convuls Ther 1994, 10:298–300.

    PubMed  CAS  Google Scholar 

  42. Jain S, Dawson J, Quinn NP, Playford ED:Occupational therapy in multiple system atrophy: a pilot randomized controlled trial.Mov Disord 2004, 19:1360–1364.

    Article  PubMed  Google Scholar 

  43. Berciano J:Olivopontocerebellar atrophy. A review of 117 cases.J. Neurol Sci 1982, 53:253–272.

    Article  PubMed  CAS  Google Scholar 

  44. Pinter MM, Alesch F, Murg M, et al.:Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus.J Neurol 1999, 246:907–913.

    Article  PubMed  CAS  Google Scholar 

  45. Puschban Z, Waldner R, Seppi K, et al.:Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy).Exp Neurol 2000, 164:166–175.

    Article  PubMed  CAS  Google Scholar 

  46. Wenning GK, Tison F, Scherfler C, et al.:Towards neurotransplantation in multiple system atrophy: clinical rationale, pathophysiological basis, and preliminary experimental evidence.Cell Transplant 2000, 9:279–288.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wesley Woods Health Center, Emory University School of Medicine, 1841 Clifton Road NE, Room 327, 30329, Atlanta, GA, USA

    Stewart A. Factor DO

Authors
  1. Christine D. Esper MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stewart A. Factor DO
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stewart A. Factor DO.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Esper, C.D., Factor, S.A. Current and future treatments in multiple system atrophy. Curr Treat Options Neurol 9, 210–223 (2007). https://doi.org/10.1007/BF02938411

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02938411

Keywords

Search

Navigation